🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00473382
Treatments Being Tested
The purpose of this study is to investigate the safety, tolerability and ef...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-10-01
Trial ID
NCT02511067
Treatments Being Tested
Ranibizumab is a humanised recombinant monoclonal antibody fragment targete...
Status
Completed
Location
Novartis - 64 sites in 11 countries
Start Date
2006-04
Trial ID
NCT00331864
Treatments Being Tested
This study is a Phase I/II, multicenter, randomized, study of the efficacy ...
Status
Completed
Location
Retina Consultants of Houston
Start Date
2012-03
Trial ID
NCT01552408
Treatments Being Tested
This study is a Phase III, double-masked, multicenter, randomized, sham inj...
Status
Completed
Location
Multiple Locations
Start Date
2007-06
Trial ID
NCT00473330
Treatments Being Tested
This was a Phase III, multicenter, randomized, double-masked, sham injectio...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00486018
Treatments Being Tested
The purpose of this research study is to determine if a "Treat and Extend" ...
Status
Completed
Location
Retina-Vitreous Associates Medical Group
Start Date
2013-11
Trial ID
NCT01934556
Treatments Being Tested
This was a Phase III, multicenter, randomized, double-masked, sham injectio...
Status
Completed
Location
Multiple Locations
Start Date
2007-07
Trial ID
NCT00485836
Treatments Being Tested
The study will test if the efficacy and safety of an alternative dosing reg...
Status
Completed
Location
Novartis
Start Date
2005-12
Trial ID
NCT00275821
The purpose of this study is to evaluate the safety, biological activity an...
Status
Completed
Location
Multiple Locations
Start Date
2015-02
Trial ID
NCT02358889
Treatments Being Tested